+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals, Tip Caps and Other Closures

  • PDF Icon

    Report

  • 385 Pages
  • May 2019
  • Region: Global
  • Roots Analysis
  • ID: 4775436
Description Jump to:

Comprehensive Analysis on the Packaging Trends of Over 230 Drug Products

Pharmaceutical packaging plays a crucial role in ensuring the sterility and quality of a drug product, while also providing information related to its identity and, in certain cases, dosing instructions. Primary packaging material, owing to the fact that it is in immediate contact with the drug/therapy formulation, is considered to be extremely important when it comes to preserving the stability, efficacy and safety of the packaged drug product. Further, given the growing complexity of modern pharmacological interventions, especially biologics, it has become imperative for drug/therapy packaging considerations to be re-evaluated, taking into consideration the evident shift from large batches of one remedy for everyone to smaller batches of more personalized therapeutic solutions. In addition to optimizing drug-packaging compatibility, stakeholders in the pharmaceutical packaging industry have also adopted a number of other flexible solutions to reduce the overall cost and expedite time to market.

The use of elastomeric materials, along with various types of coatings (such as FluoroTec® and Teflon®), has emerged as a promising alternative to conventional, non-coated closures used for primary packaging containers, which were prone to leaching and shedding of particulate contaminants. The advantages of using elastomeric materials in manufacturing container closures are many, including low leaching potential, minimal chemical interaction with the pharmacological formulation, and the fact that they can be used to make waterproof and airtight closures. Moreover, such closures can also be manufactured in the ready-to-use (RTU) format, which saves a significant amount of time by eliminating the need for multiple steps in the overall fill/finish process. Owing to the aforementioned benefits, the industry has witnessed an evident growth in preference for elastomeric container closures.

Scope of the Report

The ‘Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals, Tip Caps and Other Closures’ report features a comprehensive study of the current scenario and future potential of the elastomeric, primary packaging closure market. It features an in-depth analysis, highlighting the various types of elastomeric closures including stoppers, needle shields and plungers, available in the market for various types of primary packaging containers, such as cartridges, syringes and vials. In addition to other elements, the study includes:


  • A detailed assessment of the current market landscape of companies manufacturing elastomeric container closures, featuring information on the type of closure (cap, needle shield, plunger, seal, stopper, and tip cap), type of respective primary container(s) (vial, syringe, and cartridge), elastomeric material(s) used for fabricating the aforementioned closures (such as bromobutyl, chlorobutyl, and others), drug type(s) that are compatible with elastomeric closures, sterilization status of closures (pre-sterilized and unsterilized), affiliated sterilization technique (if the closure(s) is available in the pre-sterilized format), scale of production (small scale, and large scale), type of customization (if available), affiliated dimensions, along with compliance certifications of the product.
  • A comprehensive analysis on the packaging trends of over 230 drug products (including both biologics and small molecule drugs) that were approved over the last five years (beginning 2014), featuring an assessment of the packaging requirements of various container-closure systems based on parameters, such as year of approval of drug, type of molecule, dosage form, route of administration, holding temperature, type of packaging material(s) used for manufacturing primary container and affiliated closure, and leading drug developers (in terms of number of drugs packaged using elastomeric closures).
  • An analysis of various developments / recent trends related to elastomeric packaging materials, offering insights on [A] partnerships and collaborations established within the industry, and [B] recent global conferences related to the pharmaceutical packaging industry.
  • Elaborate profiles of key players in this domain (shortlisted on the basis of size of product portfolio), featuring a brief overview of the company (including information on company headquarters, year of establishment, number of employees, and key members of the executive team), financial information (if available), detailed description of proprietary elastomeric closures, recent developments, and an informed future outlook.
  • A case study on the role of robotics in pharmaceutical manufacturing and fill/finish operations, highlighting the advantages of using automation / automated technologies in such processes. It includes profiles of industry players offering such equipment for the aseptic processing of pharmaceutical products.
  • An elaborate discussion on emerging trends (such as the focus on personalized therapies, shift towards more flexible packaging, upgrading packaging components to enhance drug product safety, and growing adoption of smart packaging solutions) that are likely to have an impact on the future adoption of elastomeric container-closure components in the pharmaceutical packaging industry. It also features a Harvey ball analysis, highlighting the relative effect of each trend on the overall pharmaceutical packaging industry.
  • An in-depth analysis to estimate the current and future demand for elastomeric closures across key primary packaging containers, including vials, syringes and cartridges, in different regions for the period 2019-2030. Input parameters considered for this analysis include the current supply of different primary packaging components and their respective closures and the estimated the proportion of elastomeric closures that are likely to be supplied, which is indicative of the demand.
  • One of the key objectives of the report was to estimate the existing market size and identify potential growth opportunities for elastomeric closures over the coming decade. Based on several parameters, such as target consumer segments, region-specific adoption rates and expected prices of such products, we have provided an informed estimate on the likely evolution of the market over the period 2019-2030. The report provides sales forecasts for the overall elastomeric closure market, wherein both the current and upcoming opportunity is segmented across [A] type of packaging container(s) (vials, syringes and cartridges), [B] type of closure(s) used (seal, stopper, cap, plunger, barrel, and needle shield), [C] sterilization status (pre-sterilized and unsterilized), and [D] key geographies (North America, Europe, Asia-Pacific, and Rest of the World). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.

The opinions and insights presented in this study were also influenced by discussions conducted with multiple stakeholders in this domain. The report features detailed transcripts of interviews held with the following individuals (in alphabetical order of company names)


  • Julien Maréchal (Business Development and Technology Director, Aseptic Technologies)
  • Malcolm Gilmore (Facilitator, BioPhorum Operations Group)
  • Marco Pederiva (Marketing and Sales Director, Lonstroff)
  • Konstantin Kazarian (Project Manager of Business Development, PYRAMID Laboratories)

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.


Table of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Pharmaceutical Packaging
3.2.1. Types of Pharmaceutical Packaging
3.2.2. Innovation in Pharmaceutical Packaging
3.2.3. Traditional Aseptic Pharmaceutical Filling Operations
3.2.4. Limitations of Traditional Primary Packaging
3.3. Role of Containers-Closures Systems in Pharmaceutical Packaging
3.4. Types of Closures Used in Pharmaceutical Packaging
3.4.1. Closures for Syringes
3.4.2. Closures for Vials
3.4.3. Closures for Cartridges
3.5. Key Considerations for Choosing Materials for Fabricating Closures
3.6. Elastomeric Packaging Materials
3.6.1. Key Properties of Elastomeric Packaging Materials
3.6.2. Popular Types of Elastomeric Packaging Materials
3.6.3. Regulatory Guidelines for Elastomeric Closures
3.6.4. Manufacturing Process for Elastomeric Closures
3.6.5. Quality Assessment Tests for Elastomeric Closures
3.6.6. Advantages and Limitations of Elastomeric Packaging Materials
3.7. Concluding Remarks
4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Elastomeric Closures for Parenteral Containers: List of Products
4.2.1. Analysis by Type of Closure
4.2.2. Analysis by Type of Container
4.2.3. Analysis by Type of Elastomeric Material
4.2.4. Analysis by Type of Coating
4.2.5. Analysis by Drug Class
4.2.6. Analysis by Sterilization Status
4.2.7. Analysis by Sterilization Technique
4.3. Elastomeric Closures for Parenteral Containers: List of Manufacturers
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Scale of Production
4.3.4. Analysis by Location of Headquarters
4.3.5. Leading Manufacturers: Analysis by Number of Products
4.3.6. Manufacturer Landscape: Analysis by Company Size and Location of Headquarters
4.5. Elastomeric Closures for Parenteral Containers: Recent Initiatives of Players
4.5.1. List of Ready-to-Use Containers-Closure Systems
4.6. Concluding Remarks
5. COMPANY PROFILES
5.1. Chapter Overview
5.2. Key Players Based in North America
5.2.1. Aptar Pharma (a Part of AptarGroup)
5.2.1.1. Company Overview
5.2.1.2. Financial Information
5.2.1.3. Product Portfolio
5.2.1.4. Recent Developments and Future Outlook
5.2.2. DWK Life Sciences
5.2.2.1. Company Overview
5.2.2.2. Product Portfolio
5.2.2.3. Recent Developments and Future Outlook
5.2.3. West Pharmaceutical Services
5.2.3.1. Company Overview
5.2.3.2. Financial Information
5.2.3.3. Product Portfolio
5.2.3.4. Recent Developments and Future Outlook
5.3. Key Players Based in Europe
5.3.1. Datwyler Sealing Solutions (a Part of Datwyler Group)
5.3.1.1. Company Overview
5.3.1.2. Financial Information
5.3.1.3. Product Portfolio
5.3.1.4 Recent Developments and Future Outlook
5.3.2. Lonstroff (a Part of Sumitomo Rubber Industries)
5.3.2.1. Company Overview
5.3.2.2. Financial Information
5.3.2.2. Product Portfolio
5.3.2.3. Recent Developments and Future Outlook
5.3.3. Ompi (a Part of Stevanato Group)
5.3.3.1. Company Overview
5.3.3.2. Product Portfolio
5.3.3.3. Recent Developments and Future Outlook
5.4. Key Players Based in Asia-Pacific
5.4.1 Daikyo Seiko
5.4.1.1. Company Overview
5.4.1.2. Product Portfolio
5.4.1.3. Recent Developments and Future Outlook
5.4.2. Hebei First Rubber Medical Technology (a Part of DESHENG Group)
5.4.2.1. Company Overview
5.4.2.2. Product Portfolio
5.4.2.3. Recent Developments and Future Outlook
5.4.3. Jiangsu Hualan New Pharmaceutical Material
5.4.3.1. Company Overview
5.4.3.2. Product Portfolio
5.4.3.3. Recent Developments and Future Outlook
6. PACKAGING TRENDS ANALYSIS FOR RECENTLY APPROVED DRUGS
6.1. Chapter Overview
6.2. List of Approved Drugs (2014-2018)
6.2.1. Analysis by Year of Approval
6.2.2. Analysis by Type of Molecule
6.2.3. Analysis by Type of Biologic
6.2.4. Analysis by Holding Temperature Range
6.2.5. Analysis by Type of Container
6.2.6. Analysis by Type of Container and Year of Approval
6.2.7. Analysis by Type of Container and Type of Molecule
6.2.8. Analysis by Type of Container and Dosage Form
6.2.9. Analysis by Type of Container and Route of Administration
6.2.10. Analysis by Type of Container and Holding Temperature Range
6.2.11. Popular Type of Material Used for Containers
6.2.12. Analysis by Type of Closure
6.2.13. Analysis by Type of Closure and Year of Approval
6.2.14. Analysis by Type of Closure and Type of Molecule
6.2.15. Analysis by Type of Closure and Dosage Form
6.2.16. Analysis by Type of Closure and Route of Administration
6.2.17. Analysis by Type of Closure and Holding Temperature Range
6.2.18. Popular Type of Material Used for Closures
6.2.19. Analysis by Type of Elastomeric Material Used for Closures and Dosage Form
6.2.20. Analysis by Type of Elastomeric Material Used for Closures and Route of Administration
6.2.21. Analysis by Type of Elastomeric Material Used for Closures and Holding Temperature Range
6.2.22. Analysis by Type of Elastomeric Material Used for Closures
6.2.23. Most Active Players: Analysis by Number of Drugs Packaged Using Elastomeric Closures
6.2.24. Concluding Remarks
7. RECENT DEVELOPMENTS
7.1. Chapter Overview
7.2. Pharmaceutical Packaging Industry: Partnership Activity
7.2.1. Partnership Models
7.2.2. List of Partnerships and Collaborations
7.2.2.1. Analysis by Year of Partnership
7.2.2.2. Analysis by Type of Partnership
7.2.2.3. Analysis by Focus Area
7.2.2.4. Most Active Players: Analysis by Number of Partnerships
7.3. Elastomeric Container Closures in Pharmaceutical Packaging Industry: Recent Expansions
7.4. Pharmaceutical Packaging Industry: Recent Conferences
7.4.1. List of Recent Conferences
7.4.1.1. Analysis by Year of Occurrence
7.4.1.2. Analysis by Geography
7.4.2. Elastomeric Container Closures: List of Recent Conferences
7.4.2.1. Analysis by Focus Area / Agenda
7.4.3. Geographical Mapping of Conferences
7.5. Concluding Remarks
8. DEMAND ANALYSIS
8.1. Chapter Overview
8.2. Scope and Methodology
8.3. Global Demand for Elastomeric Closures, 2019-2030
8.3.1. Analysis by Type of Container
8.3.1.1. Global Demand for Elastomeric Closures for Vials
8.3.1.2. Global Demand for Elastomeric Closures for Syringes
8.3.1.3. Global Demand for Elastomeric Closures for Cartridges
8.3.2. Analysis by Type of Closure
8.3.2.1. Global Demand for Elastomeric Seals
8.3.2.2. Global Demand for Elastomeric Stoppers
8.3.2.3. Global Demand for Elastomeric Caps
8.3.2.4. Global Demand for Elastomeric Plungers
8.3.2.5. Global Demand for Elastomeric Barrels
8.3.2.6. Global Demand for Elastomeric Needle Shields
8.3.3. Analysis by Sterilization Status
8.3.3.1. Global Demand for Pre-Sterilized Elastomeric Closures
8.3.3.1.1. Global Demand for Pre-Sterilized Elastomeric Seals
8.3.3.1.2. Global Demand for Pre-Sterilized Elastomeric Stoppers
8.3.3.1.3. Global Demand for Pre-Sterilized Elastomeric Caps
8.3.3.1.4. Global Demand for Pre-Sterilized Elastomeric Plungers
8.3.3.1.5. Global Demand for Pre-Sterilized Elastomeric Barrels
8.3.3.1.6. Global Demand for Pre-Sterilized Elastomeric Needle Shields
8.3.3.2. Global Demand for Unsterilized Elastomeric Closures
8.3.3.2.1. Global Demand for Unsterilized Elastomeric Seals
8.3.3.2.2. Global Demand for Unsterilized Elastomeric Stoppers
8.3.3.2.3. Global Demand for Unsterilized Elastomeric Caps
8.3.3.2.4. Global Demand for Unsterilized Elastomeric Plungers
8.3.3.2.5. Global Demand for Unsterilized Elastomeric Barrels
8.3.3.2.6. Global Demand for Unsterilized Elastomeric Needle Shields
8.3.4. Analysis by Geography
8.3.4.1. Demand for Elastomeric Closures in North America
8.3.4.1.1. Demand for Elastomeric Seals in North America
8.3.4.1.2. Demand for Elastomeric Stoppers in North America
8.3.4.1.3. Demand for Elastomeric Caps in North America
8.3.4.1.4. Demand for Elastomeric Plungers in North America
8.3.4.1.5. Demand for Elastomeric Barrels in North America
8.3.4.1.6. Demand for Elastomeric Needle Shields in North America
8.3.4.2. Demand for Elastomeric Closures in Europe
8.3.4.2.1. Demand for Elastomeric Seals in Europe
8.3.4.2.2. Demand for Elastomeric Stoppers in Europe
8.3.4.2.3. Demand for Elastomeric Caps in Europe
8.3.4.2.4. Demand for Elastomeric Plungers in Europe
8.3.4.2.5. Demand for Elastomeric Barrels in Europe
8.3.4.2.6. Demand for Elastomeric Needle Shields in Europe
8.3.4.3. Demand for Elastomeric Closures in Asia-Pacific
8.3.4.3.1. Demand for Elastomeric Seals in Asia-Pacific
8.3.4.3.2. Demand for Elastomeric Stoppers in Asia-Pacific
8.3.4.3.3. Demand for Elastomeric Caps in Asia-Pacific
8.3.4.3.4. Demand for Elastomeric Plungers in Asia-Pacific
8.3.4.3.5. Demand for Elastomeric Barrels in Asia-Pacific
8.3.4.3.6. Demand for Elastomeric Needle Shields in Asia-Pacific
8.3.4.4. Demand for Elastomeric Closures in Rest of the World
8.3.4.4.1. Demand for Elastomeric Seals in Rest of the World
8.3.4.4.2. Demand for Elastomeric Stoppers in Rest of the World
8.3.4.4.3. Demand for Elastomeric Caps in Rest of the World
8.3.4.4.4. Demand for Elastomeric Plungers in Rest of the World
8.3.4.4.5. Demand for Elastomeric Barrels in Rest of the World
8.3.4.4.6. Demand for Elastomeric Needle Shields in Rest of the World
8.4. Concluding Remarks
9. MARKET FORECAST
9.1. Chapter Overview
9.2. Forecast Methodology and Key Assumptions
9.3. Global Elastomeric Closures Market, 2019-2030
9.3.1. Global Elastomeric Closures Market, 2019-2030: Distribution by Type of Primary Container
9.3.1.1. Global Elastomeric Closures Market for Vials, 2019-2030
9.3.1.2. Global Elastomeric Closures Market for Syringes, 2019-2030
9.3.1.3. Global Elastomeric Closures Market for Cartridges, 2019-2030
9.3.2. Global Elastomeric Closures Market, 2019-2030: Distribution by Type of Closure
9.3.2.1. Global Elastomeric Closures Market for Seals, 2019-2030
9.3.2.2. Global Elastomeric Closures Market for Stoppers, 2019-2030
9.3.2.3. Global Elastomeric Closures Market for Caps, 2019-2030
9.3.2.4. Global Elastomeric Closures Market for Plungers, 2019-2030
9.3.2.5. Global Elastomeric Closures Market for Barrels, 2019-2030
9.3.2.6. Global Elastomeric Closures Market for Needle Shields, 2019-2030
9.3.3. Global Elastomeric Closures Market, 2019-2030: Distribution by Sterilization Status
9.3.3.1. Global Pre-Sterilized Elastomeric Closures Market, 2019-2030
9.3.3.1.1. Global Pre-Sterilized Elastomeric Closures Market for Seals, 2019-2030
9.3.3.1.2. Global Pre-Sterilized Elastomeric Closures Market for Stoppers, 2019-2030
9.3.3.1.3. Global Pre-Sterilized Elastomeric Closures Market for Caps, 2019-2030
9.3.3.1.4. Global Pre-Sterilized Elastomeric Closures Market for Plungers, 2019-2030
9.3.3.1.5. Global Pre-Sterilized Elastomeric Closures Market for Barrels, 2019-2030
9.3.3.1.6. Global Pre-Sterilized Elastomeric Closures Market for Needle Shields, 2019-2030
9.3.3.2. Global Unsterilized Elastomeric Closures Market, 2019-2030
9.3.3.2.1. Global Unsterilized Elastomeric Closures Market for Seals, 2019-2030
9.3.3.2.2. Global Unsterilized Elastomeric Closures Market for Stoppers, 2019-2030
9.3.3.2.3. Global Unsterilized Elastomeric Closures Market for Caps, 2019-2030
9.3.3.2.4. Global Unsterilized Elastomeric Closures Market for Plungers, 2019-2030
9.3.3.2.5. Global Unsterilized Elastomeric Closures Market for Barrels, 2019-2030
9.3.3.2.6. Global Unsterilized Elastomeric Closures Market for Needle Shields, 2019-2030
9.3.4. Global Elastomeric Closures Market, 2019-2030: Distribution by Geography
9.3.4.1. Elastomeric Closures Market in North America, 2019-2030
9.3.4.1.1. Elastomeric Closures Market for Seals in North America, 2019-2030
9.3.4.1.2. Elastomeric Closures Market for Stoppers in North America, 2019-2030
9.3.4.1.3. Elastomeric Closures Market for Caps in North America, 2019-2030
9.3.4.1.4. Elastomeric Closures Market for Plungers in North America, 2019-2030
9.3.4.1.5. Elastomeric Closures Market for Barrels in North America, 2019-2030
9.3.4.1.6. Elastomeric Closures Market for Needle Shields in North America, 2019-2030
9.3.4.2. Elastomeric Closures Market in Europe, 2019-2030
9.3.4.2.1. Elastomeric Closures Market for Seals in Europe, 2019-2030
9.3.4.2.2. Elastomeric Closures Market for Stoppers in Europe, 2019-2030
9.3.4.2.3. Elastomeric Closures Market for Caps in Europe, 2019-2030
9.3.4.2.4. Elastomeric Closures Market for Plungers in Europe, 2019-2030
9.3.4.2.5. Elastomeric Closures Market for Barrels in Europe, 2019-2030
9.3.4.2.6. Elastomeric Closures Market for Needle Shields in Europe, 2019-2030
9.3.4.3. Elastomeric Closures Market in Asia-Pacific, 2019-2030
9.3.4.3.1. Elastomeric Closures Market for Seals in Asia-Pacific, 2019-2030
9.3.4.3.2. Elastomeric Closures Market for Stoppers in Asia-Pacific, 2019-2030
9.3.4.3.3. Elastomeric Closures Market for Caps in Asia-Pacific, 2019-2030
9.3.4.3.4. Elastomeric Closures Market for Plungers in Asia-Pacific, 2019-2030
9.3.4.3.5. Elastomeric Closures Market for Barrels in Asia-Pacific, 2019-2030
9.3.4.3.6. Elastomeric Closures Market for Needle Shields in Asia-Pacific, 2019-2030
9.3.4.4. Elastomeric Closures Market in Rest of the World, 2019-2030
9.3.4.4.1. Elastomeric Closures Market for Seals in Rest of the World, 2019-2030
9.3.4.4.2. Elastomeric Closures Market for Stoppers in Rest of the World, 2019-2030
9.3.4.4.3. Elastomeric Closures Market for Caps in Rest of the World, 2019-2030
9.3.4.4.4. Elastomeric Closures Market for Plungers in Rest of the World, 2019-2030
9.3.4.4.5. Elastomeric Closures Market for Barrels in Rest of the World, 2019-2030
9.3.4.4.6. Elastomeric Closures Market for Needle Shields in Rest of the World, 2019-2030
9.4. Concluding Remarks
10. CASE STUDY: ROBOTICS IN PHARMACEUTICAL PACKAGING
10.1. Chapter Overview
10.2. Role of Robots in the Pharmaceutical Industry
10.2.1. Key Considerations for Selecting a Robotic System
10.2.2. Advantages of Robotic Systems
10.2.3. Disadvantages of Robotic Systems
10.3. Companies Providing Robots for Pharmaceutical Industry
10.4. Companies Providing Equipment Integrated with Robotic Systems for Pharmaceutical Packaging
10.4.1. Aseptic Technologies
10.4.1.1. Crystal® L1 Robot Line
10.4.1.2. Crystal® SL1 Robot Line
10.4.2. AST
10.4.2.1. ASEPTiCell® Series
10.4.2.2. ASEPTiCell® VSM-25
10.4.3. Bosch Packaging Technology
10.4.3.1. ATO
10.4.4. Dara Pharmaceutical Packaging
10.4.4.1. SYX-E CARTRIDGE + RABS
10.4.5. Fedegari Group
10.4.5.1. Fedegari Isolator
10.4.6. IMA
10.4.6.1. INJECTA
10.4.6.2. STERI LIF3
10.4.7. Steriline
10.4.7.1. Nest Filling Line RNFM
10.4.8. Vanrx Pharmasystems
10.4.8.1. Microcell Vial Filler
10.4.8.2. SA25 Aseptic Filling Workcell
11. EMERGING TRENDS IN PHARMACEUTICAL PACKAGING
11.1. Chapter Overview
11.2. Shift Towards Self-Medication using Advanced Drug Delivery Devices
11.3. Focus on Developing Improved Packaging Components and Ongoing Efforts to Optimize Manufacturing Costs
11.4. Availability of Modular Facilities
11.5. Initiatives Focused on Automation of Fill / Finish Operations
11.6. Establishment of Business Relationships Focused on Designing Compatible Packaging Materials for Various Drug Products
11.7. Increasing Activity in Developing Regions
11.8. Growing Adoption of Smart Packaging Solutions
11.9. Concluding Remarks
12. EXECUTIVE INSIGHTS
12.1. Chapter Overview
12.2. Aseptic Technologies
12.2.1. Company Snapshot
12.2.2. Interview Transcript: Julien Maréchal, Business Development and Technology Director
12.3. BioPhorum Operations Group
12.3.1. Company Snapshot
12.3.2. Interview Transcript: Malcolm Gilmore, Facilitator
12.4. Lonstroff
12.4.1. Company Snapshot
12.4.2. Interview Transcript: Marco Pederiva, Marketing and Sales Director
12.5. PYRAMID Laboratories
12.5.1. Company Snapshot
12.5.2. Interview Transcript: Konstantin Kazarian, Business Development Project Manager
13. APPENDIX 1: TABULATED DATA14. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
List of Figures
Figure 3.1. Advantages of Pharmaceutical Packaging
Figure 3.2. Types of Pharmaceutical Packaging
Figure 3.3. Innovation in Pharmaceutical Packaging
Figure 3.4. Traditional Aseptic Pharmaceutical Filling
Figure 3.5. List of Various Primary Packaging Containers-Closures Systems
Figure 3.6. Applications of Elastomeric Materials in Various Industries
Figure 3.7. Key Properties of Elastomeric Materials
Figure 3.8. Comparison of Different Types of Packaging Materials
Figure 3.9. Advantages and Limitations of Elastomeric Materials Used in Pharmaceutical Packaging Industry
Figure 4.1. Elastomeric Closures for Parenteral Containers: Distribution by Type of Closure
Figure 4.2. Elastomeric Closures for Parenteral Containers: Distribution by Type of Container
Figure 4.3. Elastomeric Closures for Parenteral Containers: Distribution by Type of Elastomeric Material
Figure 4.4. Elastomeric Closures for Parenteral Containers: Distribution by Sterilization Status
Figure 4.5. Elastomeric Closures for Parenteral Containers: Distribution by Sterilization Technique
Figure 4.6. Elastomeric Closures for Parenteral Containers: Distribution by Type of Coating
Figure 4.7. Elastomeric Closures for Parenteral Containers: Distribution by Drug Class
Figure 4.8. Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Year of Establishment
Figure 4.9. Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Company Size
Figure 4.10. Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Scale of Production
Figure 4.11. Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Location of Headquarters
Figure 4.12. Leading Manufacturers: Distribution by Number of Products
Figure 4.13. Manufacturer Landscape: Distribution by Company Size and Location of Headquarters
Figure 5.1. AptarGroup: Annual Revenues, 2013-Q3 2018 (USD Billion)
Figure 5.2. West Pharmaceutical Services: Annual Revenues, 2013-2018 (USD Billion)
Figure 5.3. Datwyler Group: Annual Revenues, 2013-2018 (CHF Million)
Figure 5.4. Sumitomo Rubber Industries: Annual Revenues, 2013-2018 (Yen Billion)
Figure 5.5. Sumitomo Rubber Industries: Annual Revenues by Business Segments, 2018
Figure 6.1. Approved Drugs (2014-2018): Distribution by Year of Approval
Figure 6.2. Approved Drugs (2014-2018): Distribution by Type of Molecule
Figure 6.3. Approved Drugs (2014-2018): Distribution by Type of Biologic
Figure 6.4. Approved Drugs (2014-2018): Distribution by Holding Temperature Range
Figure 6.5. Approved Drugs (2014-2018): Distribution by Type of Container
Figure 6.6. Approved Drugs (2014-2018): Distribution by Type of Container and Year of Approval
Figure 6.7. Approved Drugs (2014-2018): Distribution by Type of Container and Type of Molecule
Figure 6.8. Approved Drugs (2014-2018): Distribution by Type of Container and Dosage Form
Figure 6.9. Approved Drugs (2014-2018): Distribution by Type of Container and Route of Administration
Figure 6.10. Approved Drugs (2014-2018): Distribution by Type of Container and Holding Temperature Range
Figure 6.11. Approved Drugs (2014-2018): Popular Type of Material Used for Containers in Biologics
Figure 6.12. Approved Drugs (2014-2018): Popular Type of Material Used for Containers in Small Molecule
Figure 6.13. Approved Drugs (2014-2018): Distribution by Type of Closure
Figure 6.14. Approved Drugs (2014-2018): Distribution by Type of Closure and Year of Approval
Figure 6.15. Approved Drugs (2014-2018): Distribution by Type of Closure and Type of Molecule
Figure 6.16. Approved Drugs (2014-2018): Distribution by Type of Closure and Dosage Form
Figure 6.17. Approved Drugs (2014-2018): Distribution by Type of Closure and Route of Administration
Figure 6.18. Approved Drugs (2014-2018): Distribution by Type of Closure and Holding Temperature Range
Figure 6.19. Approved Drugs (2014-2018): Popular Type of Material Used for Closures in Biologics
Figure 6.20. Approved Drugs (2014-2018): Popular Type of Material Used for Closures in Small Molecules
Figure 6.21. Approved Drugs (2014-2018): Distribution by Type of Elastomeric Material Used for Closures and Dosage Form
Figure 6.22. Approved Drugs (2014-2018): Distribution by Type of Elastomeric Material Used for Closures and Route of Administration
Figure 6.23. Approved Drugs (2014-2018): Distribution by Type of Elastomeric Material Used for Closures and Holding Temperature Range
Figure 6.24. Approved Drugs (2014-2018): Distribution by Type of Elastomeric Material Used for Closures
Figure 6.25. Most Active Players: Distribution by Number of Drugs Packaged using Elastomeric Closures
Figure 6.26. Approved Drugs (2014-2018), Grid Analysis: Distribution by Type of Container, Closure, Type of Material and Route of Administration
Figure 6.27. Approved Drugs (2014-2018), Bubble Analysis: Distribution by Type of Closure, Type of Elastomeric Material and Type of Molecule
Figure 7.1. Partnerships and Collaborations: Cumulative Trend by Year, Pre-2015-2019
Figure 7.2. Partnerships and Collaborations: Distribution by Type of Partnership
Figure 7.3. Partnerships and Collaborations: Distribution by Focus Area
Figure 7.4. Partnerships and Collaborations: Most Active Players
Figure 7.5. Global Conferences: Cumulative Year-Wise Trend, 2015-2019
Figure 7.6. Global Conferences: Distribution by Location
Figure 7.7. Global Conferences Related to Elastomeric Containers Closures: Key Focus Areas
Figure 7.8. Global Conferences: Geographical Mapping
Figure 8.1. Global Demand for Elastomeric Closures: Methodology and Key Assumptions
Figure 8.2. Global Demand for Elastomeric Closures, 2019-2030 (Billion Units)
Figure 8.3. Global Demand for Elastomeric Closures: Distribution by Type of Container, 2019 and 2030
Figure 8.4. Global Demand for Elastomeric Closures for Vials, 2019-2030 (Billion Units)
Figure 8.5. Global Demand for Elastomeric Closures for Syringes, 2019-2030 (Billion Units)
Figure 8.6. Global Demand for Elastomeric Closures for Cartridges, 2019-2030 (Billion Units)
Figure 8.7. Global Demand for Elastomeric Closures: Distribution by Type of Closure, 2019 and 2030
Figure 8.8. Global Demand for Elastomeric Seals, 2019-2030 (Billion Units)
Figure 8.9. Global Demand for Elastomeric Stoppers, 2019-2030 (Billion Units)
Figure 8.10. Global Demand for Elastomeric Caps, 2019-2030 (Billion Units)
Figure 8.11. Global Demand for Elastomeric Plungers, 2019-2030 (Billion Units)
Figure 8.12. Global Demand for Elastomeric Barrels, 2019-2030 (Billion Units)
Figure 8.13. Global Demand for Elastomeric Needle Shields, 2019-2030 (Billion Units)
Figure 8.14. Global Demand for Elastomeric Closures: Distribution by Sterilization Status, 2019 and 2030
Figure 8.15. Global Demand for Elastomeric Pre-Sterilized Elastomeric Closures, 2019-2030 (Billion Units)
Figure 8.16. Global Demand for Elastomeric Pre-Sterilized Elastomeric Seals, 2019-2030 (Billion Units)
Figure 8.17. Global Demand for Elastomeric Pre-Sterilized Elastomeric Stoppers, 2019-2030 (Billion Units)
Figure 8.18. Global Demand for Elastomeric Pre-Sterilized Elastomeric Caps, 2019-2030 (Billion Units)
Figure 8.19. Global Demand for Elastomeric Pre-Sterilized Elastomeric Plungers, 2019-2030 (Billion Units)
Figure 8.20. Global Demand for Elastomeric Pre-Sterilized Elastomeric Barrels, 2019-2030 (Billion Units)
Figure 8.21. Global Demand for Elastomeric Pre-Sterilized Elastomeric Needle Shields, 2019-2030 (Billion Units)
Figure 8.22. Global Demand for Elastomeric Unsterilized Elastomeric Closures, 2019-2030 (Billion Units)
Figure 8.23. Global Demand for Elastomeric Unsterilized Elastomeric Seals, 2019-2030 (Billion Units)
Figure 8.24. Global Demand for Elastomeric Unsterilized Elastomeric Stoppers, 2019-2030 (Billion Units)
Figure 8.25. Global Demand for Elastomeric Unsterilized Elastomeric Caps, 2019-2030 (Billion Units)
Figure 8.26. Global Demand for Elastomeric Unsterilized Elastomeric Plungers, 2019-2030 (Billion Units)
Figure 8.27. Global Demand for Elastomeric Unsterilized Elastomeric Barrels, 2019-2030 (Billion Units)
Figure 8.28. Global Demand for Elastomeric Unsterilized Elastomeric Needle Shields, 2019-2030 (Billion Units)
Figure 8.29. Global Demand for Elastomeric Closures: Distribution by Geography, 2019 and 2030
Figure 8.30. Demand for Elastomeric Seals in North America, 2019-2030 (Billion Units)
Figure 8.31. Demand for Elastomeric Stoppers in North America, 2019-2030 (Billion Units)
Figure 8.32. Demand for Elastomeric Caps in North America, 2019-2030 (Billion Units)
Figure 8.33. Demand for Elastomeric Plungers in North America, 2019-2030 (Billion Units)
Figure 8.34. Demand for Elastomeric Barrels in North America, 2019-2030 (Billion Units)
Figure 8.35. Demand for Elastomeric Needle Shields in North America, 2019-2030 (Billion Units)
Figure 8.36. Demand for Elastomeric Closures in Europe, 2019-2030 (Billion Units)
Figure 8.37. Demand for Elastomeric Seals in Europe, 2019-2030 (Billion Units)
Figure 8.38. Demand for Elastomeric Stoppers in Europe, 2019-2030 (Billion Units)
Figure 8.39. Demand for Elastomeric Caps in Europe, 2019-2030 (Billion Units)
Figure 8.40. Demand for Elastomeric Plungers in Europe, 2019-2030 (Billion Units)
Figure 8.41. Demand for Elastomeric Barrels in Europe, 2019-2030 (Billion Units)
Figure 8.42. Demand for Elastomeric Needle Shields in Europe, 2019-2030 (Billion Units)
Figure 8.43. Demand for Elastomeric Closures in Asia-Pacific, 2019-2030 (Billion Units)
Figure 8.44. Demand for Elastomeric Seals in Asia-Pacific, 2019-2030 (Billion Units)
Figure 8.45. Demand for Elastomeric Stoppers in Asia-Pacific, 2019-2030 (Billion Units)
Figure 8.46. Demand for Elastomeric Caps in Asia-Pacific, 2019-2030 (Billion Units)
Figure 8.47. Demand for Elastomeric Plungers in Asia-Pacific, 2019-2030 (Billion Units)
Figure 8.48. Demand for Elastomeric Barrels in Asia-Pacific, 2019-2030 (Billion Units)
Figure 8.49. Demand for Elastomeric Needle Shields in Asia-Pacific, 2019-2030 (Billion Units)
Figure 8.50. Demand for Elastomeric Closures in Rest of the World, 2019-2030 (Billion Units)
Figure 8.51. Demand for Elastomeric Seals in Rest of the World, 2019-2030 (Billion Units)
Figure 8.52. Demand for Elastomeric Stoppers in Rest of the World, 2019-2030 (Billion Units)
Figure 8.53. Demand for Elastomeric Caps in Rest of the World, 2019-2030 (Billion Units)
Figure 8.54. Demand for Elastomeric Plungers in Rest of the World, 2019-2030 (Billion Units)
Figure 8.55. Demand for Elastomeric Barrels in Rest of the World, 2019-2030 (Billion Units)
Figure 8.56. Demand for Elastomeric Needle Shields in Rest of the World, 2019-2030 (Billion Units)
Figure 9.1. Global Elastomeric Closures Market: Forecast Methodology and Key Assumptions
Figure 9.2. Global Elastomeric Closures Market, 2019-2030 (USD Billion)
Figure 9.3. Global Elastomeric Closures Market, 2019-2030: Distribution by Type of Primary Container (USD Billion)
Figure 9.4. Global Elastomeric Closures Market for Vials, 2019-2030 (USD Billion)
Figure 9.5. Global Elastomeric Closures Market for Syringes, 2019-2030 (USD Billion)
Figure 9.6. Global Elastomeric Closures Market for Cartridges, 2019-2030 (USD Billion)
Figure 9.7. Global Elastomeric Closures Market, 2019-2030: Distribution by Type of Closure (USD Billion)
Figure 9.8. Global Elastomeric Closures Market for Seals, 2019-2030 (USD Billion)
Figure 9.9. Global Elastomeric Closures Market for Stoppers, 2019-2030 (USD Billion)
Figure 9.10. Global Elastomeric Closures Market for Caps, 2019-2030 (USD Billion)
Figure 9.11. Global Elastomeric Closures Market for Plungers, 2019-2030 (USD Billion)
Figure 9.12. Global Elastomeric Closures Market for Barrels, 2019-2030 (USD Billion)
Figure 9.13. Global Elastomeric Closures Market for Needle Shields, 2019-2030 (USD Billion)
Figure 9.14. Global Elastomeric Closures Market, 2019-2030: Distribution by Sterilization Status (USD Billion)
Figure 9.15. Global Pre-Sterilized Elastomeric Closures Market, 2019-2030 (USD Billion)
Figure 9.16. Global Pre-Sterilized Elastomeric Closures Market for Seals, 2019-2030 (USD Billion)
Figure 9.17. Global Pre-Sterilized Elastomeric Closures Market for Stoppers, 2019-2030 (USD Billion)
Figure 9.18. Global Pre-Sterilized Elastomeric Closures Market for Caps, 2019-2030 (USD Billion)
Figure 9.19. Global Pre-Sterilized Elastomeric Closures Market for Plungers, 2019-2030 (USD Billion)
Figure 9.20. Global Pre-Sterilized Elastomeric Closures Market for Barrels, 2019-2030 (USD Billion)
Figure 9.21. Global Pre-Sterilized Elastomeric Closures Market for Needle Shields, 2019-2030 (USD Billion)
Figure 9.22. Global Unsterilized Elastomeric Closures Market, 2019-2030 (USD Billion)
Figure 9.23. Global Unsterilized Elastomeric Closures Market for Seals, 2019-2030 (USD Billion)
Figure 9.24. Global Unsterilized Elastomeric Closures Market for Stoppers, 2019-2030 (USD Billion)
Figure 9.25. Global Unsterilized Elastomeric Closures Market for Caps, 2019-2030 (USD Billion)
Figure 9.26. Global Unsterilized Elastomeric Closures Market for Plungers, 2019-2030 (USD Billion)
Figure 9.27. Global Unsterilized Elastomeric Closures Market for Barrels, 2019-2030 (USD Billion)
Figure 9.28. Global Unsterilized Elastomeric Closures Market for Needle Shields, 2019-2030 (USD Billion)
Figure 9.29. Elastomeric Closures Market, 2019-2030: Distribution by Geography (USD Billion)
Figure 9.30. Elastomeric Closures Market in North America, 2019-2030 (USD Billion)
Figure 9.31. Elastomeric Closures Market for Seals in North America, 2019-2030 (USD Billion)
Figure 9.32. Elastomeric Closures Market for Stoppers in North America, 2019-2030 (USD Billion)
Figure 9.33. Elastomeric Closures Market for Caps in North America, 2019-2030 (USD Billion)
Figure 9.34. Elastomeric Closures Market for Plungers in North America, 2019-2030 (USD Billion)
Figure 9.35. Elastomeric Closures Market for Barrels in North America, 2019-2030 (USD Billion)
Figure 9.36. Elastomeric Closures Market for Needle Shields in North America, 2019-2030 (USD Billion)
Figure 9.37. Elastomeric Closures Market in Europe, 2019-2030 (USD Billion)
Figure 9.38. Elastomeric Closures Market for Seals in Europe, 2019-2030 (USD Billion)
Figure 9.39. Elastomeric Closures Market for Stoppers in Europe, 2019-2030 (USD Billion)
Figure 9.40. Elastomeric Closures Market for Caps in Europe, 2019-2030 (USD Billion)
Figure 9.41. Elastomeric Closures Market for Plungers in Europe, 2019-2030 (USD Billion)
Figure 9.42. Elastomeric Closures Market for Barrels in Europe, 2019-2030 (USD Billion)
Figure 9.43. Elastomeric Closures Market for Needle Shields in Europe, 2019-2030 (USD Billion)
Figure 9.44. Elastomeric Closures Market in Asia-Pacific, 2019-2030 (USD Billion)
Figure 9.45. Elastomeric Closures Market for Seals in Asia-Pacific, 2019-2030 (USD Billion)
Figure 9.46. Elastomeric Closures Market for Stoppers in Asia-Pacific, 2019-2030 (USD Billion)
Figure 9.47. Elastomeric Closures Market for Caps in Asia-Pacific, 2019-2030 (USD Billion)
Figure 9.48. Elastomeric Closures Market for Plungers in Asia-Pacific, 2019-2030 (USD Billion)
Figure 9.49. Elastomeric Closures Market for Barrels in Asia-Pacific, 2019-2030 (USD Billion)
Figure 9.50. Elastomeric Closures Market for Needle Shields in Asia-Pacific, 2019-2030 (USD Billion)
Figure 9.51. Elastomeric Closures Market in Rest of the World, 2019-2030 (USD Billion)
Figure 9.52. Elastomeric Closures Market for Seals in Rest of the World, 2019-2030 (USD Billion)
Figure 9.53. Elastomeric Closures Market for Stoppers in Rest of the World, 2019-2030 (USD Billion)
Figure 9.54. Elastomeric Closures Market for Caps in Rest of the World, 2019-2030 (USD Billion)
Figure 9.55. Elastomeric Closures Market for Plungers in Rest of the World, 2019-2030 (USD Billion)
Figure 9.56. Elastomeric Closures Market for Barrels in Rest of the World, 2019-2030 (USD Billion)
Figure 9.57. Elastomeric Closures Market for Needle Shields in Rest of the World, 2019-2030 (USD Billion)
Figure 9.58. Overall Elastomeric Closures Market: Conservative, Base and Optimistic Scenario, 2019, 2024 and 2030 (USD Billion)
Figure 10.1. Key Considerations to Select a Robot
Figure 10.2. Advantages of Robotic Systems in Pharmaceutical Operations
Figure 11.1. Emerging Trends Related to Pharmaceutical Packaging
Figure 11.2. Future Growth Opportunities Related to Elastomeric Closures
List of Tables
Table 3.1. Key Components of Syringes
Table 3.2. Popular Types of Elastomeric Packaging Materials
Table 3.3. Popular Coatings / Surface Treatment Methods Used for Elastomeric Closures
Table 4.1. List of Elastomeric Closures for Parenteral Containers
Table 4.2. Elastomeric Closures for Parenteral Containers: Information on Type of Container
Table 4.3. Elastomeric Closures for Parenteral Containers: Information on Type of Elastomeric Material and Type of Drug Class
Table 4.4. Elastomeric Closures for Parenteral Containers: Information on Sterilization Status
Table 4.5. Elastomeric Closures for Parenteral Containers: Additional Information
Table 4.6. Elastomeric Closures for Parenteral Containers: Information on Manufacturers
Table 4.7. Elastomeric Closures for Parenteral Containers: Information on Scale of Operation of Manufacturers
Table 4.8. List of Ready-to-Use Containers-Closures Systems
Table 5.1. AptarGroup: Company Overview
Table 5.2. Aptar Pharma: Product Details
Table 5.3. AptarGroup: Recent Developments and Future Outlook
Table 5.4. DWK Life Sciences: Company Overview
Table 5.5. DWK Life Sciences: Product Details
Table 5.6. DWK Life Sciences: Recent Developments and Future Outlook
Table 5.7. West Pharmaceutical Services: Company Overview
Table 5.8. West Pharmaceutical Services: Product Details
Table 5.9. West Pharmaceutical Services: Recent Developments and Future Outlook
Table 5.10. Datwyler Sealing Solutions (a Part of Datwyler Group): Company Overview
Table 5.11. Datwyler Sealing Solutions (a Part of Datwyler Group): Product Details
Table 5.12. Datwyler Sealing Solutions (a Part of Datwyler Group) : Recent Developments and Future Outlook
Table 5.13. Lonstroff: Company Overview
Table 5.14. Sumitomo Rubber Industries: Company Overview
Table 5.15. Lonstroff: Product Details
Table 5.16. Sumitomo Rubber Industries: Recent Developments and Future Outlook
Table 5.17. Ompi (a Part of Stevanato Group): Company Overview
Table 5.18. Ompi (a Part of Stevanato Group): Product Details
Table 5.19. Ompi (a Part of Stevanato Group): Recent Developments and Future Outlook
Table 5.20. Daikyo Seiko: Company Overview
Table 5.21. Daikyo Seiko: Product Details
Table 5.22. Daikyo Seiko: Recent Developments and Future Outlook
Table 5.23. Hebei First Rubber Medical Technology: Company Overview
Table 5.24. Hebei First Rubber Medical Technology: Product Details
Table 5.25. Jiangsu Hualan New Pharmaceutical Material: Company Overview
Table 5.26. Jiangsu Hualan New Pharmaceutical Material: Product Details
Table 6.1. List of Approved Drugs (2014-2018): Information on Dosage Form, Route of Administration and Holding Temperature Range
Table 6.2. List of Approved Drugs (2014-2018): Information on Type of Container and Container Material
Table 6.3. List of Approved Drugs (2014-2018): Information on Type of Closure and Closure Material
Table 7.1. List of Partnerships and Collaborations: Information on Year and Type, 2007-2019
Table 7.2. List of Partnerships and Collaborations: Information on Focus Area and Product Type, 2007-2019
Table 7.3. List of Recent Expansions, 2014-2018
Table 7.4. Pharmaceutical Packaging Industry: List of Conferences, 2013-2019
Table 7.5. Conferences Related to Elastomeric Containers Closures: Information of Focus Area / Agenda
Table 7.6. Conferences Related to Elastomeric Containers Closures: Information on Key Speakers
Table 10.1. Pharmaceutical Robotics Manufacturers
Table 10.2. Aseptic Technologies: Company Overview
Table 10.3. Aseptic Technologies: Key Specifications of Crystal® L1 Robot Line
Table 10.4. Aseptic Technologies: Key Specifications of Crystal® SL1 Robot Line
Table 10.5. AST: Company Overview
Table 10.6. AST: Key Specifications of ASEPTiCell® Series
Table 10.7. AST: Key Specifications of ASEPTiCell® VSM-25
Table 10.8. Bosch Packaging Technology: Company Overview
Table 10.9. Bosch Packaging Technology: Key Specifications of ATO
Table 10.10. Dara Pharmaceutical Packaging: Company Overview
Table 10.11. Dara Pharmaceutical Packaging: Key Specifications of SYX-E CARTRIDGE + RABS
Table 10.12. Fedegari Group: Company Overview
Table 10.13. Fedegari Group: Key Specifications of Fedegari Isolator
Table 10.14. IMA: Company Overview
Table 10.15. IMA: Key Specifications of INJECTA
Table 10.16. IMA: Key Specifications of STERI LIF3
Table 10.17. Steriline: Company Overview
Table 10.18. Steriline: Key Specifications of Nest Filling Line RNFM
Table 10.19. Vanrx Pharmasystems: Company Overview
Table 10.20. Vanrx Pharmasystems: Key Specifications of Microcell Vial Filler
Table 10.21. Vanrx Pharmasystems: Key Specifications of SA25 Aseptic Filling Workcell
Table 12.1. Aseptic Technologies: Company Snapshot
Table 12.2. BioPhorum Operations Group: Company Snapshot
Table 12.3. Lonstroff: Company Snapshot
Table 12.4. PYRAMID Laboratories: Company Snapshot
Table 13.1. Elastomeric Closures for Parenteral Containers: Distribution by Type of Closure
Table 13.2. Elastomeric Closures for Parenteral Containers: Distribution by Type of Container
Table 13.3. Elastomeric Closures for Parenteral Containers: Distribution by Type of Elastomeric Material
Table 13.4. Elastomeric Closures for Parenteral Containers: Distribution by Sterilization Status
Table 13.5. Elastomeric Closures for Parenteral Containers: Distribution by Sterilization Technique
Table 13.6. Elastomeric Closures for Parenteral Containers: Distribution by Type of Coating
Table 13.7. Elastomeric Closures for Parenteral Containers: Distribution by Type of Drug Class
Table 13.8. Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Year of Establishment
Table 13.9. Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Company Size
Table 13.10. Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Scale of Production
Table 13.11. Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Location of Headquarters
Table 13.12. Leading Manufacturers: Distribution by Number of Products
Table 13.13. AptarGroup: Annual Revenues, 2013-Q3 2018 (USD Billion)
Table 13.14. West Pharmaceutical Services: Annual Revenues, 2013-2018 (USD Billion)
Table 13.15. Datwyler Group: Annual Revenues, 2013-2018 (CHF Million)
Table 13.16. Sumitomo Rubber Industries: Annual Revenues, 2013-2018 (Yen Billion)
Table 13.17. Sumitomo Rubber Industries: Annual Revenues by Business Segment, 2018
Table 13.18. Approved Drugs (2014-2018): Distribution by Year of Approval
Table 13.19. Approved Drugs (2014-2018): Distribution by Type of Molecule
Table 13.20. Approved Drugs (2014-2018): Distribution by Type of Biologic
Table 13.21. Approved Drugs (2014-2018): Distribution by Holding Temperature Range
Table 13.22. Approved Drugs (2014-2018): Distribution by Type of Container
Table 13.23. Approved Drugs (2014-2018): Distribution by Type of Container and Year of Approval
Table 13.24. Approved Drugs (2014-2018): Distribution by Type of Container and Type of Molecule
Table 13.25. Approved Drugs (2014-2018): Distribution by Type of Container and Dosage Form
Table 13.26. Approved Drugs (2014-2018): Distribution by Type of Container and Route of Administration
Table 13.27. Approved Drugs (2014-2018): Distribution by Type of Container and Holding Temperature Range
Table 13.28. Approved Drugs (2014-2018): Popular Type of Material Used for Containers in Biologics
Table 13.29. Approved Drugs (2014-2018): Popular Type of Material Used for Containers in Small Molecule
Table 13.30. Approved Drugs (2014-2018): Distribution by Type of Closure
Table 13.31. Approved Drugs (2014-2018): Distribution by Type of Closure and Year of Approval
Table 13.32. Approved Drugs (2014-2018): Distribution by Type of Closure and Type of Molecule
Table 13.33. Approved Drugs (2014-2018): Distribution by Type of Closure and Dosage Form
Table 13.34. Approved Drugs (2014-2018): Distribution by Type of Closure and Route of Administration
Table 13.35. Approved Drugs (2014-2018): Distribution by Type of Closure and Holding Temperature Range
Table 13.36. Approved Drugs (2014-2018): Popular Type of Material Used for Closures in Biologics
Table 13.37. Approved Drugs (2014-2018): Popular Type of Material Used for Closures in Small Molecules
Table 13.38. Approved Drugs (2014-2018): Distribution by Type of Elastomeric Material Used for Closures and Dosage Form
Table 13.39. Approved Drugs (2014-2018): Distribution by Type of Elastomeric Material Used for Closures and Route of Administration
Table 13.40. Approved Drugs (2014-2018): Distribution by Type of Elastomeric Material Used for Closures and Holding Temperature Range
Table 13.41. Approved Drugs (2014-2018): Distribution by Types of Elastomeric Material Used for Closures
Table 13.42. Most Active Players: Distribution by Number of Drugs Packaged Using Elastomeric Closures
Table 13.43. Partnerships and Collaborations: Cumulative Trend by Year, Pre-2015-2019
Table 13.44. Partnerships and Collaborations: Distribution by Type of Partnership
Table 13.45. Partnerships and Collaborations: Distribution by Focus Area
Table 13.46. Partnerships and Collaborations: Most Active Players
Table 13.47. Global Conferences: Cumulative Year-Wise Trend, 2015-2019
Table 13.48. Global Conferences: Distribution by Location
Table 13.49. Global Demand for Elastomeric Closures, 2019-2030 (Billion Units)
Table 13.50. Global Demand for Elastomeric Closures: Distribution by Type of Container, 2019 and 2030
Table 13.51. Global Demand for Elastomeric Closures for Vials, 2019-2030 (Billion Units)
Table 13.52. Global Demand for Elastomeric Closures for Syringes, 2019-2030 (Billion Units)
Table 13.53. Global Demand for Elastomeric Closures for Cartridges, 2019-2030 (Billion Units)
Table 13.54. Global Demand for Elastomeric Closures: Distribution by Type of Closure, 2019 and 2030
Table 13.55. Global Demand for Elastomeric Seals, 2019-2030 (Billion Units)
Table 13.56. Global Demand for Elastomeric Stoppers, 2019-2030 (Billion Units)
Table 13.57. Global Demand for Elastomeric Caps, 2019-2030 (Billion Units)
Table 13.58. Global Demand for Elastomeric Plungers, 2019-2030 (Billion Units)
Table 13.59. Global Demand for Elastomeric Barrels, 2019-2030 (Billion Units)
Table 13.60. Global Demand for Elastomeric Needle Shields, 2019-2030 (Billion Units)
Table 13.61. Global Demand for Elastomeric Closures: Distribution by Sterilization Status, 2019 and 2030
Table 13.62. Global Demand for Elastomeric Pre-Sterilized Elastomeric Closures, 2019-2030 (Billion Units)
Table 13.63. Global Demand for Elastomeric Pre-Sterilized Elastomeric Seals, 2019-2030 (Billion Units)
Table 13.64. Global Demand for Elastomeric Pre-Sterilized Elastomeric Stoppers, 2019-2030 (Billion Units)
Table 13.65. Global Demand for Elastomeric Pre-Sterilized Elastomeric Caps, 2019-2030 (Billion Units)
Table 13.66. Global Demand for Elastomeric Pre-Sterilized Elastomeric Plungers, 2019-2030 (Billion Units)
Table 13.67. Global Demand for Elastomeric Pre-Sterilized Elastomeric Barrels, 2019-2030 (Billion Units)
Table 13.68. Global Demand for Elastomeric Pre-Sterilized Elastomeric Needle Shields, 2019-2030 (Billion Units)
Table 13.69. Global Demand for Elastomeric Unsterilized Elastomeric Closures, 2019-2030 (Billion Units)
Table 13.70. Global Demand for Elastomeric Unsterilized Elastomeric Seals, 2019-2030 (Billion Units)
Table 13.71. Global Demand for Elastomeric Unsterilized Elastomeric Stoppers, 2019-2030 (Billion Units)
Table 13.72. Global Demand for Elastomeric Unsterilized Elastomeric Caps, 2019-2030 (Billion Units)
Table 13.73. Global Demand for Elastomeric Unsterilized Elastomeric Plungers, 2019-2030 (Billion Units)
Table 13.74. Global Demand for Elastomeric Unsterilized Elastomeric Barrels, 2019-2030 (Billion Units)
Table 13.75. Global Demand for Elastomeric Unsterilized Elastomeric Needle Shields, 2019-2030 (Billion Units)
Table 13.76. Global Demand for Elastomeric Closures: Distribution by Geography, 2019 and 2030
Table 13.77. Demand for Elastomeric Seals in North America, 2019-2030 (Billion Units)
Table 13.78. Demand for Elastomeric Stoppers in North America, 2019-2030 (Billion Units)
Table 13.79. Demand for Elastomeric Caps in North America, 2019-2030 (Billion Units)
Table 13.80. Demand for Elastomeric Plungers in North America, 2019-2030 (Billion Units)
Table 13.81. Demand for Elastomeric Barrels in North America, 2019-2030 (Billion Units)
Table 13.82. Demand for Elastomeric Needle Shields in North America, 2019-2030 (Billion Units)
Table 13.83. Demand for Elastomeric Closures in Europe, 2019-2030 (Billion Units)
Table 13.84. Demand for Elastomeric Seals in Europe, 2019-2030 (Billion Units)
Table 13.85. Demand for Elastomeric Stoppers in Europe, 2019-2030 (Billion Units)
Table 13.86. Demand for Elastomeric Caps in Europe, 2019-2030 (Billion Units)
Table 13.87. Demand for Elastomeric Plungers in Europe, 2019-2030 (Billion Units)
Table 13.88. Demand for Elastomeric Barrels in Europe, 2019-2030 (Billion Units)
Table 13.89. Demand for Elastomeric Needle Shields in Europe, 2019-2030 (Billion Units)
Table 13.90. Demand for Elastomeric Closures in Asia-Pacific, 2019-2030 (Billion Units)
Table 13.91. Demand for Elastomeric Seals in Asia-Pacific, 2019-2030 (Billion Units)
Table 13.92. Demand for Elastomeric Stoppers in Asia-Pacific, 2019-2030 (Billion Units)
Table 13.93. Demand for Elastomeric Caps in Asia-Pacific, 2019-2030 (Billion Units)
Table 13.94. Demand for Elastomeric Plungers in Asia-Pacific, 2019-2030 (Billion Units)
Table 13.95. Demand for Elastomeric Barrels in Asia-Pacific, 2019-2030 (Billion Units)
Table 13.96. Demand for Elastomeric Needle Shields in Asia-Pacific, 2019-2030 (Billion Units)
Table 13.97. Demand for Elastomeric Closures in Rest of the World, 2019-2030 (Billion Units)
Table 13.98. Demand for Elastomeric Seals in Rest of the World, 2019-2030 (Billion Units)
Table 13.99. Demand for Elastomeric Stoppers in Rest of the World, 2019-2030 (Billion Units)
Table 13.100. Demand for Elastomeric Caps in Rest of the World, 2019-2030 (Billion Units)
Table 13.101. Demand for Elastomeric Plungers in Rest of the World, 2019-2030 (Billion Units)
Table 13.102. Demand for Elastomeric Barrels in Rest of the World, 2019-2030 (Billion Units)
Table 13.103. Demand for Elastomeric Needle Shields in Rest of the World, 2019-2030 (Billion Units)
Table 13.104. Global Elastomeric Closures Market, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.105. Global Elastomeric Closures Market, 2019-2030: Distribution by Type of Primary Container (USD Billion)
Table 13.106. Global Elastomeric Closures Market for Vials, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.107. Global Elastomeric Closures Market for Syringes, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.108. Global Elastomeric Closures Market for Cartridges, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.109. Global Elastomeric Closures Market, 2019-2030: Distribution by Type of Closure (USD Billion)
Table 13.110. Global Elastomeric Closures Market for Seals, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.111. Global Elastomeric Closures Market for Stoppers, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.112. Global Elastomeric Closures Market for Caps, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.113. Global Elastomeric Closures Market for Plungers, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.114. Global Elastomeric Closures Market for Barrels, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.115. Global Elastomeric Closures Market for Needle Shields, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.116. Global Elastomeric Closures Market, 2019-2030: Distribution by Sterilization Status (USD Billion)
Table 13.117. Global Pre-Sterilized Elastomeric Closures Market, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.118. Global Pre-Sterilized Elastomeric Closures Market for Seals, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.119. Global Pre-Sterilized Elastomeric Closures Market for Stoppers, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.120. Global Pre-Sterilized Elastomeric Closures Market for Caps, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.121. Global Pre-Sterilized Elastomeric Closures Market for Plungers, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.122. Global Pre-Sterilized Elastomeric Closures Market for Barrels, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.123. Global Pre-Sterilized Elastomeric Closures Market for Needle Shields, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.124. Global Unsterilized Elastomeric Closures Market, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.125. Global Unsterilized Elastomeric Closures Market for Seals, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.126. Global Unsterilized Elastomeric Closures Market for Stoppers, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.127. Global Unsterilized Elastomeric Closures Market for Caps, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.128. Global Unsterilized Elastomeric Closures Market for Plungers, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.129. Global Unsterilized Elastomeric Closures Market for Barrels, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.130. Global Unsterilized Elastomeric Closures Market for Needle Shields, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.131. Global Elastomeric Closures Market, 2019-2030: Distribution by Geography (USD Billion)
Table 13.132. Elastomeric Closures Market in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.133. Elastomeric Closures Market for Seals in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.134. Elastomeric Closures Market for Stoppers in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.135. Elastomeric Closures Market for Caps in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.136. Elastomeric Closures Market for Plungers in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.137. Elastomeric Closures Market for Barrels in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.138. Elastomeric Closures Market for Needle Shields in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.139. Elastomeric Closures Market in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.140. Elastomeric Closures Market for Seals in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.141. Elastomeric Closures Market for Stoppers in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.142. Elastomeric Closures Market for Caps in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.143. Elastomeric Closures Market for Plungers in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.144. Elastomeric Closures Market for Barrels in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.145. Elastomeric Closures Market for Needle Shields in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.146. Elastomeric Closures Market in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.147. Elastomeric Closures Market for Seals in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.148. Elastomeric Closures Market for Stoppers in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.149. Elastomeric Closures Market for Caps in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.150. Elastomeric Closures Market for Plungers in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.151. Elastomeric Closures Market for Barrels in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.152. Elastomeric Closures Market for Needle Shields in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.153. Elastomeric Closures Market in Rest of the World, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.154. Elastomeric Closures Market for Seals in Rest of the World, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.155. Elastomeric Closures Market for Stoppers in Rest of the World, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.156. Elastomeric Closures Market for Caps in Rest of the World, 2019-2030 (USD Billion)
Table 13.157. Elastomeric Closures Market for Plungers in Rest of the World, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.158. Elastomeric Closures Market for Barrels in Rest of the World, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.159. Elastomeric Closures Market for Needle Shields in Rest of the World, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)

Executive Summary

Chapter Outlines

Chapter 2 provides an executive summary of the insights captured during our research. It offers a high-level view on the current state of the market of elastomeric closures and its likely evolution in the short-mid term and long term.

Chapter 3 provides an overview of conventional pharmaceutical packaging and the limitations associated with the currently used container-closure systems. The chapter also lays emphasis on innovation in the pharmaceutical packaging industry and the consequent growth of flexible fill / finish solutions. It features an elaborate discussion on the different considerations for choosing a suitable material for fabricating container-closure systems. Further, the chapter includes a detailed discussion on elastomeric materials, highlighting their properties, and applications across various industries. In addition, it provides an overview of regulatory guidelines associated with elastomeric container-closure systems. It elaborates on the various tests that are necessary to assess and control the quality of elastomeric closures. It concludes with a brief discussion on the advantages and limitations of elastomeric closures, highlighting the growing importance of coated elastomeric materials.

Chapter 4 provides a comprehensive review of the current market landscape of nearly 100 elastomeric closures. It includes a detailed analysis of the aforementioned products based on the type of closure (cap, needle shield, plunger, seal, stopper, and tip cap), type of respective primary container(s) (vial, syringe, and cartridge), elastomeric material(s) used for fabricating the aforementioned closures (such as bromobutyl, chlorobutyl, and others), drug type(s) that are compatible with elastomeric closures, sterilization status of closures (pre-sterilized and unsterilized), affiliated sterilization technique (if closure(s) is available in the pre-sterilized format), scale of production (small scale, and large scale), type of customization (if available), affiliated dimensions, along with compliance certifications of the product. It also provides details of the manufacturer companies, such as year of establishment, company size, and location of headquarters.

Chapter 5 features detailed profiles of key players (shortlisted on the basis of size of product portfolio) that are involved in fabricating and supplying elastomeric closures. Each company profile features a brief overview of the company (including information on company headquarters, year of establishment, number of employees, and key members of executive team), financial information (if available), detailed descriptions of proprietary elastomeric closures, recent developments and an informed future outlook.

Chapter 6 features packaging trends of over 230 drugs products (including both biologics and small molecule drugs) that were approved over the last five years (beginning 2014). The chapter comprises of in-depth analyses, highlighting the packaging requirements of various container-closure systems based on several parameters, including year of approval of drug, type of molecule, dosage form, route of administration, holding temperature, type of packaging material(s) used for manufacturing primary container and affiliated closure. Furthermore, we have highlighted the leading players in this domain, based on the number of approved drugs packaged using elastomeric closures in the given time period.

Chapter 7 features a detailed assessment of various developments / recent trends related to elastomeric packaging materials. The analysis presented in this chapter offers insights on [A] recent partnerships and collaborations that have been established in the last decade, featuring a comprehensive set of analyses, based on various parameters, such as the year of establishment and headquarters of each company, type of partnership, purpose of collaboration, and type of product, and [B] recent global conferences related to pharmaceutical packaging industry, featuring a set of analyses based on various parameters, such as year, location, and agenda of the conference.

Chapter 8 provides an overview of the current and future demand for elastomeric closures for key primary packaging containers, including vials, syringes and cartridges, in the contemporary market. In order to estimate the aforementioned demand, we considered the current supply of different primary packaging components and their respective closures and estimated the proportion of elastomeric closures that are likely to be supplied to the pharmaceutical industry. We also estimated the likely adoption of such products across geographical regions, over the period 2019-2030.

Chapter 9 presents a comprehensive market forecast analysis, highlighting the future potential of the market till 2030, based on multiple parameters, such as current demand for respective packaging components, likely adoption rates and the estimated price of components. It includes future sales projections of various closures of key packaging containers. We have segregated the current and upcoming opportunity on the basis of [A] type of packaging container(s) (vials, syringes and cartridges), [B] type of packaging closure(s) (seal, stopper, cap, plunger, barrel, and needle shield), [C] sterilization status (pre-sterilized and unsterilized), and [D] key geographies (North America, Europe and, Asia-Pacific and Rest of the World). It is worth mentioning that we adopted a bottom-up approach for this analysis, backing our claims with relevant datapoints and credible inputs from primary research.

Chapter 10 presents an elaborate case study on the role of robots in the pharmaceutical manufacturing and fill / finish process. It features a list of the various types of pharmaceutical robots, along with details on their respective manufacturer(s) and applications. Further, the chapter includes profiles of players that offer robotic machinery for pharmaceutical manufacturing and fill / finish operations, along with information on the key specifications of such products. 

Chapter 11 discusses key trends in the overall pharmaceutical manufacturing industry. Specifically, it elaborates on the emerging focus on personalized therapies, shift towards more flexible packaging, development of modular facilities, upgrading packaging components to enhance drug product safety, increase in partnership activity, and growing adoption of smart packaging solutions, among others.

Chapter 12 is a collection of interview transcripts of discussions held with key stakeholders in this market. In this chapter, we have presented the details of interviews held with (in alphabetical order of company names) Julien Maréchal (Business Development and Technology Director, Aseptic Technologies), Malcolm Gilmore (Facilitator, BioPhorum Operations Group), Marco Pederiva (Marketing and Sales Director, Lonstroff), and Konstantin Kazarian (Project manager of Business Development Project Manager, PYRAMID Laboratories).

Chapter 13 is an appendix, which provides tabulated data and numbers for all the figures included in the report.

Chapter 14 is an appendix, which provides the list of companies and organizations mentioned in this report.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • ABB
  • ACADIA Pharmaceuticals
  • APG Europe
  • API Pharma
  • ARLANXEO
  • ARaymond Life
  • AbbVie
  • Abu Dhabi Polytechnic
  • Accurate Elastomer Products
  • AcelRx Pharmaceuticals
  • Achaogen
  • Acme Vial and Glass
  • Acorda Therapeutics
  • Actelion Pharmaceuticals
  • Advanced Accelerator Applications
  • AdvantaPure
  • Aerie Pharmaceuticals
  • Afton Scientific
  • Agios Pharmaceuticals
  • AkaRx
  • Akcea Therapeutics
  • Alcon Laboratories
  • Alexion Pharmaceuticals
  • Alkermes
  • Allergan
  • Allergy Laboratories
  • Almirall
  • Amcor
  • Amgen
  • Amphastar Pharmaceuticals
  • Anacor Pharmaceuticals
  • Anhui Huafeng Pharmaceutical Rubber
  • Anhui Zhongma Rubber & Plastic Products
  • Antares Pharma
  • Aptar CSP Technologies
  • Aptar Pharma
  • Aquestive Therapeutics
  • Ariad Pharmaceuticals
  • Array BioPharma
  • Aseptic Technologies
  • Assem-Pak
  • Astellas Pharma
  • AstraZeneca
  • Automated Systems of Tacoma (AST)
  • BV Holdings
  • Balda Group (part of Stevanato Group)
  • Bausch & Lomb
  • Bausch Health
  • Bayer
  • Becton Dickinson
  • Berry Global
  • Bespak
  • Bharat Rubber Works
  • BioCryst Pharmaceuticals
  • BioMarin Pharmaceutical
  • BioPhorum Operations Group
  • Biogen
  • Black Frame Advisors
  • BloodWorks Northwest
  • Blue Earth
  • Boehringer Ingelheim
  • Bosch Packaging Technology
  • Bracco Diagnostics
  • Bright Indotech
  • Bristol-Myers Squibb (BMS)
  • C Otto Gehrckens
  • CSPC Pharmaceutical Group
  • Caps and Seals
  • Catalyst Pharmaceuticals
  • Celgene
  • Celltrion
  • Chelsea Therapeutics
  • Chemo Research
  • Chiesi USA
  • Ciron Drugs
  • Cixi Lixin Rubber
  • Cleveland Cord Blood Center
  • Clovis Oncology
  • Cole-Parmer
  • Columbia Engineered Rubber
  • Corning
  • Cosmo Pharmaceuticals
  • Cubist Pharmaceuticals
  • DENSO
  • DSM Hydrocolloids
  • DWK Life Sciences
  • Daiichi Sankyo
  • Daikyo Seiko
  • Danyang Jincheng Medical Rubber & Plastics
  • Dara Pharmaceutical Packaging
  • Datwyler Sealing Solutions
  • Dayou Trading
  • Debiotech
  • Dow Corning
  • DowDuPont Specialty Products (DuPont) Division
  • Duke University School of Medicine
  • Duran Group
  • Durata Therapeutics
  • EMA Pharmaceuticals
  • EMD Serono
  • Eastman Chemical
  • Eisai
  • Eli Lilly
  • Elusys Therapeutics
  • Enable Injections
  • ExxonMobil Chemical
  • EyePoint Pharmaceuticals
  • FANUC America
  • Fedegari Group
  • Ferrer
  • Fibrocell Technologies
  • Fresenius Kabi
  • GCL Pharma
  • GE Healthcare Life Sciences
  • Genentech
  • German Institute of Rubber Technology (DIK)
  • Gerresheimer
  • Gilead Sciences
  • GlaxoSmithKline
  • Greenwich Biosciences
  • H K Zion Industry
  • HealthPrize Technologies
  • Hebei First Rubber Medical Technology
  • Helsinn Healthcare
  • Henan Zhengzhou Songshan Enterprise Group
  • Hubei Huaqiang High-Tech
  • Hunan Runfuture Pharmatech
  • IPM Technologies
  • ITF Pharma
  • Industria Macchine Automatiche (IMA)
  • Infinity Pharmaceuticals
  • Insmed
  • Insulet
  • Intercept Pharmaceuticals
  • Ionis Pharmaceuticals
  • Ironwood Pharmaceuticals
  • JOTOP GLASS
  • Jain Rubbers
  • Jamnadas Industries
  • Janssen
  • Jazz Pharmaceuticals
  • Jiangsu Best New Medical Material
  • Jiangsu Hualan New Pharmaceutical Material
  • Jiangyin Aisun Import & Export
  • Jiangyin Chengfeng Rubber and Plastic
  • Jiangyin Hongmeng Rubber Plastic Product
  • Jiangyin Tejie Rubber & Plastic
  • Jiangyin Yonghong Rubber
  • Jinan Youlyy Industrial
  • KAI Pharmaceuticals
  • KUKA
  • KWK Kremsmünster
  • KYTHERA Biopharmaceuticals
  • Kali Care
  • Kawasaki Heavy Industries
  • Kimble Chase
  • Kite Pharma
  • Kraton
  • Kwality Pharma Rubber Industries
  • Kyoraku
  • La Jolla Pharmaceutical Company
  • Lanxess
  • Leadiant Biosciences
  • Leibniz Association
  • Lexicon Pharmaceuticals
  • LifeSouth Community Blood Centers
  • Lonstroff
  • Loxo Oncology
  • Lupin
  • MJS Packaging
  • Malaysian Rubber Board
  • Marchesini Group
  • Massman Automation Designs
  • Mayne Pharma
  • Medicines Development for Global Health
  • Megaplast
  • Melinta Therapeutics
  • Merck
  • Millennium Pharmaceuticals
  • Millipore Sigma
  • Mitsubishi Tanabe Pharma
  • Momentive
  • Motiba Silicone
  • Mylan
  • NPS Pharmaceuticals
  • Naniwa Rubber
  • National University of Ireland, Galway
  • Neelam Global
  • Neurocrine Biosciences
  • Neutral Glass and Allied Industries
  • New York Blood Center
  • NextPharma Technologies
  • Ningbo Xingya Rubber & Plastic
  • Ningbo Zhengli Pharmaceutical Packing
  • Nipro PharmaPackaging
  • Noble International
  • Nordson EFD
  • Novartis
  • Novimmune
  • Novio
  • Novo Nordisk
  • OMRON Industrial Automation
  • Ocular Therapeutics
  • Ohio State University
  • Ompi (part of Stevanato Group)
  • Organogenesis
  • Organon International
  • Ortho Dermatologics
  • Otsuka Pharmaceutical
  • Ott
  • PTC Therapeutics
  • PYRAMID Laboratories
  • Pack Source
  • Paladin Labs
  • Pall Biotech
  • Pall Life Sciences
  • Paratek Pharmaceuticals
  • Pfizer
  • PharMediPack Direkt
  • Piramal Imaging
  • Plas-Tech Engineering
  • PolyOne
  • Polytec Industries
  • Portola Pharmaceuticals
  • Prince Rubber & Plastics
  • Prince Sterilization Services
  • Propeller Health
  • Prysmian Group
  • Puma Biotechnology
  • Puyang Lumeng Glass Product
  • Qindao Huaren Medical
  • Qure Medical
  • RAUMEDIC
  • Radius Health
  • Regeneron Pharmaceuticals
  • Relypsa
  • Rempex Pharmaceuticals
  • Retrophin
  • Rigel Pharmaceuticals
  • Rizhao Donggang Mtntai Industry and Trade
  • Roche
  • RubberMill
  • SCHOTT
  • SCHOTT-KAISHA
  • SHRIJI Rubber Industries
  • SIGA Technologies
  • SIGMA Plastic Services
  • SKAN
  • SSM Health Cardinal Glennon Children's Hospital
  • SVM Automatik
  • Sagar Rubber Products
  • Samsung Medical Rubber
  • Sanofi
  • Sanofi Genzyme
  • Sarepta Therapeutics
  • Seiko Epson
  • Servier
  • Shady Pack
  • Shandong Pharmaceutical Glass
  • Sheng Zou Rubber & Plastics
  • Shenzhen Fushiyuan Rubber and Plastic Factory
  • Shionogi
  • Shire Pharmaceuticals
  • Shreenidhi Rubber
  • Shrinath Products (a division of Elmer Products)
  • Shyam Well Pack Industries
  • Sonata Rubber
  • Spark Therapeutics
  • Spectrum Pharmaceuticals
  • Splendid Industry
  • Sprout Pharmaceuticals
  • Staubli
  • Stemline Therapeutics
  • Steriline
  • Stock Cap
  • Strongbridge Biopharma
  • Sumitomo Rubber Industries
  • Sun Pharmaceutical Industries
  • SureCare
  • Synergy Pharmaceuticals
  • TESARO
  • TaiMed Biologics
  • Taiho Oncology
  • Taiwan Ta Sheh Heng Yi Enterprise Group
  • Taizhou Kanglong Pharmaceutical Packing
  • Takeda Pharmaceuticals
  • Tekpak
  • Tetraphase Pharmaceuticals
  • Teva Pharmaceutical Industries
  • Teva Respiratory (part of Teva Pharmaceutical Industries)
  • The Medicines Company
  • The Plasticoid Company
  • TherapeuticsMD
  • Theravance Biopharma
  • Tip-Top
  • Tohoku University
  • Triveni Polymers
  • Tyndall National Institute
  • UD Pharma Rubber Products
  • US WorldMeds
  • Ultragenyx Pharmaceutical
  • Union Chimique Belge
  • United Scientific Supplies
  • United Therapeutics
  • Universal Medicap
  • Universal Robots
  • University of Colorado Cord Blood Bank
  • Urologix
  • VWR (a part of Avantor)
  • Valeant Pharmaceuticals
  • Vanda Pharmaceuticals
  • Vanrx Pharmasystems
  • Verastem Oncology
  • Vericel
  • Vertex Pharmaceuticals
  • Verux
  • Vighnesh Rubbers
  • Viscon Rubber
  • VitaMed
  • Vital Parts
  • Weidmann Medical Technology
  • Wellstat Therapeutics
  • West Pharmaceutical Services
  • Wheaton Industries
  • Wyeth
  • Xiamen Petrel Rubber & Plastic Products
  • Yangjiang Jinbi Rubber Products
  • Yangzhong Wealth Metal
  • Yantai Xinhui Packing
  • Yaskawa Electric
  • Yichang Huaqiang Trade
  • Zhengzhou Aoxiang Pharmaceutical Packing
  • Zibo Dongda Medical Rubber

Methodology

 

 

Loading
LOADING...

Related Topics

Related Reports

Prefilled Syringes Market, Industry Trends and Global Forecasts, till 2035: Distribution by Purpose of Syringe, Therapeutic Area, Type of Molecule, Type of Needle System, Usability of Syringe, Type of Syringe, Type of Packaging and Key Geographical Regions - Product Image

Prefilled Syringes Market, Industry Trends and Global Forecasts, till 2035: Distribution by Purpose of Syringe, Therapeutic Area, Type of Molecule, Type of Needle System, Usability of Syringe, Type of Syringe, Type of Packaging and Key Geographical Regions

  • Report
  • 867 Pages
  • Global
From
Safety Syringes Market by Product, Application, End-User - Global Forecast 2025-2030 - Product Image

Safety Syringes Market by Product, Application, End-User - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Prefilled Syringe Market: Trends, Opportunities and Competitive Analysis - Product Image

Prefilled Syringe Market: Trends, Opportunities and Competitive Analysis

  • Report
  • 226 Pages
  • Global
From
Pharmaceutical Packaging Market by Type (Bottle, Vial, Blister Pack, Ampoule, Pre-filled Syringe), Material (Plastic [PE, Polyvinyl chloride, PP, PET], Paper, Glass, Metal), Dosage Form (Oral, Parenteral, Topical), End User-Global Forecast to 2031 - Product Image

Pharmaceutical Packaging Market by Type (Bottle, Vial, Blister Pack, Ampoule, Pre-filled Syringe), Material (Plastic [PE, Polyvinyl chloride, PP, PET], Paper, Glass, Metal), Dosage Form (Oral, Parenteral, Topical), End User-Global Forecast to 2031

  • Report
  • 200 Pages
  • Global
From
Prefilled Syringes - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Prefilled Syringes - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.